By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MabVax Therapeutics, Inc. 

11588 Sorrento Valley Road
Suite 20
San Diego  California  92121  U.S.A
Phone: 858-259-9405 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
MabVax Therapeutics, Inc.' Human Antibody Clinical Development Candidate HuMab 5B1 Successfully Clears Important Early Toxicology Testing 5/5/2015 6:28:22 AM
MabVax Therapeutics, Inc. Appoints Tom Varvaro To Its Board Of Directors 4/7/2015 9:45:01 AM
MabVax Therapeutics, Inc. Announces Closing Of Financing 4/6/2015 8:00:52 AM
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015 6:23:04 AM
MabVax Therapeutics, Inc. To Present At The 27th Annual Roth Conference 3/3/2015 10:35:31 AM
MabVax Therapeutics, Inc. Selected To Present At 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:16:22 AM
MabVax Therapeutics, Inc. Selected To Make Corporate Presentation At January 2015 BIOTECH Showcase 12/11/2014 8:30:07 AM
MabVax Therapeutics, Inc. And Memorial Sloan-Kettering Cancer Center Report On Potential Use Of Dual-Labeled Antibody To Detect And Guide Surgical Removal Of Pancreatic Cancer 11/19/2014 3:59:46 PM
MabVax Therapeutics, Inc. Launches Online Corporate Communication Channels And New Website 10/23/2014 8:48:21 AM
MabVax Therapeutics, Inc. Nominates The Fully Human Antibody HuMab 5B1 As The Company's Lead Clinical Development Candidate 10/21/2014 9:16:20 AM
123
//-->